Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Novartis AG
  6. News
  7. All News
    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
Delayed Swiss Exchange  -  11:30 2022-12-07 am EST
85.78 CHF   +0.59%
12:07pGlobal markets live: Glencore, Apple, Netflix, Tesla, Amazon...
MS
09:55aMorphoSys Out Licenses Pre-Clinical Oncology Program
AQ
06:09aNOVARTIS AG : Gets a Sell rating from Deutsche Bank
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about NOVARTIS AG
12:07pGlobal markets live: Glencore, Apple, Netflix, Tesla, Amazon...
MS
09:55aMorphoSys Out Licenses Pre-Clinical Oncology Program
AQ
06:09aNOVARTIS AG : Gets a Sell rating from Deutsche Bank
MD
12/06Novartis Signs Licensing Deal for MorphoSys Unit's Cancer Program
MT
12/06Novartis' Combination Breast Cancer Therapy Boosts Progression-free Survival in Mid-sta..
MT
12/06Novartis Says Kisqali Results in Better Progression-Free Survival Than Chemotherapy in ..
MT
12/06Novartis Kisqali« prolonged PFS benefit for pre- and perimenopausal patients with aggre..
GL
12/06Novartis Kisqali(R) prolonged PFS benefit for pre- and perimenopausal patients with agg..
DJ
12/06NOVARTIS AG : UBS reiterates its Neutral rating
MD
12/06BNP Paribas Lowers Price Target on Novartis, Maintains Neutral Recommendation
MT
12/06Bank Vontobel Lifts Price Target on Novartis, Maintains Buy Recommendation
MT
12/05ADRs End Lower, Vodafone and Glencore Trade Actively
DJ
12/05Gloomy Eurozone Services PMI Weights on Sentiment as Most European Bourses End in the R..
MT
12/05Stifel Upgrades Recommendation on Novartis to Buy From Hold
MT
12/05Novartis Prostate Cancer Drug Trial Meets Primary Endpoint
DJ
12/05Novartis' Prostate Cancer Drug Extends Progression-free Survival In Late-stage Study
MT
12/05Novartis PluvictoTM shows statistically significant and clinically meaningful radiograp..
GL
12/05Novartis PluvictoTM shows statistically significant and clinically meaningful radiograp..
DJ
12/05Novartis AG Pluvicto Shows Statistically Significant and Clinically Meaningful Radiogra..
CI
12/01European Court Of Justice Issues Lan : No Repackaging/Rebranding As The Originator Referen..
AQ
11/30Transcript : Novartis AG - Special Call
CI
11/30Intron Health Lifts Price Target on Novartis, Maintains Buy Recommendation
MT
11/29AstraZeneca boosts cancer portfolio with $320 mln Neogene deal
RE
11/24Novartis and Medicines for Malaria Venture announce decision to move to Phase 3 study f..
AQ
11/23Novartis, Medicines for Malaria Venture to Kick Off Phase 3 Study for Uncomplicated Mal..
MT
11/23Novartis : and Medicines for Malaria Venture announce decision to move to Phase 3 study fo..
PU
11/22Novartis' Sandoz, Teva Pharmaceutical Partner To Expand Biosimilars Production
MT
11/22Generic drugmakers Teva and Sandoz make major push to biosimilars
RE
11/22Novartis highlights scientific advances with Kisqali, iptacopan, Scemblix and YTB323 da..
GL
11/22Teva Pharmaceutical Industries, Sandoz Plan to Boost Production of Biosimilars
MT
11/22NOVARTIS AG : Gets a Sell rating from Deutsche Bank
MD
11/22CORRECTED (OFFICIAL) -FOCUS-Generic drugmakers Teva and Sandoz make major push to biosi..
RE
11/21Teva Pharmaceutical Names Richard Francis as President, CEO
DJ
11/21Teva hires ex-Novartis executive to succeed CEO Schultz
RE
11/17Cisen Pharmaceutical Gets Regulatory Approval for Registration of Two Drugs
MT
11/16Higher UK Inflation Helps Snap European Stock Rally
MT
11/16Novartis Mulling Sale of Ophthalmology, Respiratory Units
MT
11/16Novartis Mulls Sale of Opthalmology, Respiratory Businesses, Bloomberg Reports
DJ
11/16Novartis Reportedly Weighs Sale of Ophthalmology, Respiratory Units
CI
11/16Novartis Seeks Fresh Funds from Sale of Ophthalmology, Respiratory Units
MT
11/16Novartis weighs sale of opthalmology, respiratory units - Bloomberg
RE
11/15Teva Pharmaceutical Industries Wins UK Court Case Over Novartis' 2 European Drug Patent..
MT
11/15Stifel Lifts Price Target on Novartis, Maintains Hold Recommendation
MT
11/14BioNTech to Set Up mRNA Manufacturing Facility in Singapore
MT
11/13BioNTech Acquires Singapore Facility to Produce mRNA Vaccines
DJ
11/13BioNTech's Singapore Unit To Purchase Novartis' Local Manufacturing Site In Asian Expan..
MT
11/13Germany's BioNTech says to set up mRNA vaccine facility in Singapore
RE
11/11Sector Update: Tech Stocks Surge for Second Consecutive Session
MT
11/11Sector Update: Tech Stocks Surging Again on Friday
MT
11/11EU Clears Xbrane-STADA's Biosimilar of Novartis' Eye Drug Lucentis
MT
11/10AlphaValue/Baader Europe Lowers Price Target on Novartis, Maintains Add Recommendation
MT
11/10AstraZeneca beats forecasts on cancer drug sales
RE
11/09Zacks Lifts Price Target on Novartis, Maintains Neutral Recommendation
MT
11/08Global markets live: Bayer, Lyft, Nintendo, Gap, Exxon Mobil...
MS
11/07Novartis' Leqvio Shows Sustained Cholesterol Reduction in Long-term Data
MT
11/07New long-term Leqvio« (inclisiran) data from Novartis show sustained efficacy and safet..
GL
11/07New long-term Leqvio(R) (inclisiran) data from Novartis show sustained efficacy and saf..
DJ
11/07Novartis Unit Sandoz to Invest Additional $50 Million in Penicillin Manufacturing
MT
11/07Novartis's Sandoz to Invest $50 Million in Austrian Facility to Boost Antibiotic Produc..
MT
11/07Novartis adds 50 mln euros to European antibiotics investment budget
RE
11/07Sandoz announces further investment in key manufacturing facility in Austria, to suppor..
GL
11/07Novartis : Sandoz announces further investment in key manufacturing facility in..
DJ
11/03Actinium Appoints Seasoned Leader Caroline Yarbrough as Chief Commercial Officer to Spe..
AQ
11/02Biogen Seeks A Preliminary Injunction In Natalizumab BPCIA Case Against Sandoz
AQ
11/01FTSE 100 Closes Tuesday Up 1.3% Boosted by Miners; Ocado's Surge
DJ
10/31Glenmark Pharmaceuticals Launches Fingolimod Capsules in US
MT
10/27AlphaValue/Baader Europe Lowers Price Target on Novartis, Maintains Add Recommendation
MT
10/27NOVARTIS AG : Gets a Sell rating from Deutsche Bank
MD
10/26NOVARTIS AG : Bernstein reaffirms its Neutral rating
MD
10/26NOVARTIS AG : Credit Suisse maintains a Sell rating
MD
10/26AlphaValue/Baader Europe Lowers Price Target on Novartis, Maintains Add Recommendation
MT
10/26DA Davidson Adjusts Price Target on Novartis ADR to $90 From $99, Reiterates Buy/Add Ra..
MT
10/26NOVARTIS AG : JP Morgan reaffirms its Sell rating
MD
10/26NOVARTIS AG : Barclays keeps a Sell rating
MD
10/25EU Bourses Close Higher Tuesday; HSBC Drags FTSE 100 Lower
MT
1  2  3  4  5  6  7  8  9  10Next